Implementation of genomic surveillance of Sars-CoV-2 in the Caribbean

The COVID-19 pandemic highlighted the importance of global genomic surveillance to monitor the emergence and spread of SARS-CoV-2 variants and inform public health decision-making. Until December 2020 there was minimal capacity for viral genomic surveillance in most Caribbean countries. To overcome this constraint, the COVID-19: Infectious disease Molecular epidemiology for PAthogen Control & Tracking (COVID-19 IMPACT) project was implemented to establish rapid SARS-CoV-2 whole genome nanopore sequencing at The University of the West Indies (UWI) in Trinidad and Tobago (T&T) and provide needed SARS-CoV-2 sequencing services for T&T and other Caribbean Public Health Agency Member States (CMS). Using the Oxford Nanopore Technologies MinION sequencing platform and ARTIC network sequencing protocols and bioinformatics pipeline, a total of 3610 SARS-CoV-2 positive RNA samples, received from 17 CMS, were sequenced in-situ during the period December 5 th 2020 to December 31 st 2021. Ninety-one Pango lineages, including those of five variants of concern (VOC), were identified. Genetic analysis revealed at least 260 introductions to the CMS from other global regions. For each of the 17 CMS, the percentage of reported COVID-19 cases sequenced by the COVID-19 IMPACT laboratory ranged from 0·02% to 3·80% (median = 1·12%). Sequences submitted to GISAID by our study represented 73·3% of all SARS-CoV-2 sequences from the 17 CMS available on the database up to December 31 st 2021. Increased staffing, process and infrastructural improvement over the course of the project helped reduce turnaround times for reporting to originating institutions and sequence uploads to GISAID. Insights from our genomic surveillance network in the Caribbean region directly influenced non-pharmaceutical countermeasures in the CMS countries. However, limited availability of associated surveillance and clinical data made it challenging to contextualise the observed SARS-CoV-2 diversity and evolution, highlighting the need for development of infrastructure for collecting and integrating genomic sequencing data and sample-associated metadata

Biology · Disease · DNA sequencing · Gene · Genome · Genomics · Geography · Minion · Nanopore sequencing · Pandemic · Public health · Whole genome sequencing · COVID-19 Clinical Research Studies · Medicine · SARS-CoV-2 and COVID-19 Research · SARS-CoV-2 detection and testing · Genetics · Virology

• University consortium to address public health priorities and research capacity building in the Caribbean

  Open Access•Allison Li, John Lindo et al.•Frontiers in Education•2023

  Incluir item

• Building up a genomic surveillance platform for Sars-CoV-2 in the middle of a pandemic

  Open Access•Waqasuddin Khan, Furqan Kabir et al.•BMJ Global Health•2023

  Incluir item

• Laboratory readiness and genomic surveillance of Covid-19 in the capital of Brazil

  Open Access•Francisca Verônica Cavalcante, Christina Pacheco Santos Martins et al.•PLOS Global Public Health•2025

  Incluir item

• Posterior Summarization in Bayesian Phylogenetics Using Tracer 1.7

  Open Access•Andrew Rambaut, Alexei J Drummond et al.•Systematic Biology•2018

  Incluir item

• A new coronavirus associated with human respiratory disease in China

  Open Access•Fan Wu, Zhao Su et al.•Nature•2020

  Incluir item

• Iq-Tree 2

  Open Access•Bui Quang Minh, Heiko A Schmidt et al.•Molecular Biology and Evolution•2020

  Incluir item

• A Novel Coronavirus from Patients with Pneumonia in China, 2019

  Na Zhu, 양승민 양승민 et al.•New England Journal of Medicine•2020

  Incluir item